International Journal of STD & AIDS > Volume 10, Number 1 > Pp. 38-42

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petruckevitch, A. Articles by Cock, K. M D. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Risk of cancer in patients with HIV disease

Ann Petruckevitch, Julia Del Amo, Andrew N Phillips, Judith M Stephenson, Anne M Johnson and Kevin M De Cock

The aim of this study was to compare cancer incidence in a cohort of HIV-infected patients with the incidence rates in the population of South East England. Data collected for a retrospective cohort study of 2048 HIV-infected patients were analysed to examine the incidence of cancer. Cases of cancer occurring in South East England from 1985-1995 were obtained from the Thames Cancer Registry. Standardized incidence ratios were calculated by comparison of the observed number of cases for each cancer type in HIV-infected non-Africans with the numbers expected, calculated from the age and sex specific registration rates for the South East England population using person-years of observation. The crude incidence rates of cancer were calculated for HIV-infected Africans. The incidence of non-AIDS defining cancers such as Hodgkin's disease (standardized incidence ratio 22; 95% CI: 3-80) and anal cancer (standardized incidence ratio 125; 95% CI: 3-697) were significantly increased for non-African males with HIV disease. Anal cancer was also significantly increased for nonAfrican females (standardized incidence ratio 1667; 95% CI: 43-9287). Kaposi's sarcoma (KS) was the commonest cancer among HIV-infected Africans and males had an incidence which was nearly 3 times that of females. There is evidence to suggest that the risks for other non-AIDS defining cancers were significantly increased in persons with HIV disease which may have implications for HIV/AIDS surveillance.

Key Words: HIV INCIDENCE SOUTH EAST ENGLAND RETROSPECTIVE POPULATION

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B Mester, A Nieters, E Deeg, G Elsner, N Becker, and A Seidler Occupation and malignant lymphoma: a population based case control study in Germany Occup. Environ. Med., January 1, 2006; 63(1): 17 - 26. [Abstract] [Full Text] [PDF]

				M. Herida, M. Mary-Krause, R. Kaphan, J. Cadranel, I. Poizot-Martin, C. Rabaud, N. Plaisance, H. Tissot-Dupont, F. Boue, J.-M. Lang, et al. Incidence of Non-AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus-Infected Patients J. Clin. Oncol., September 15, 2003; 21(18): 3447 - 3453. [Abstract] [Full Text] [PDF]

				M. Frisch, R. J. Biggar, E. A. Engels, J. J. Goedert, and for the AIDS-Cancer Match Registry Study Group Association of Cancer With AIDS-Related Immunosuppression in Adults JAMA, April 4, 2001; 285(13): 1736 - 1745. [Abstract] [Full Text] [PDF]

				J. Biagi, R. G. MacKenzie, M. S. Lim, M. Sapp, and N. Berinstein Primary Hodgkin's disease of the CNS in an immunocompetent patient: A case study and review of the literature Neuro-oncol, October 1, 2000; 2(4): 239 - 243. [Abstract] [PDF]